SCHEMBL8335064

SCHEMBL8335064

COc1cccc(CCC(=O)c2cc(C(=O)NCc3ccc(CC(=O)NC4CCCCC4)cc3)ncn2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.51
▸ EPHX2 P34913 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ CNR2 P34972 1/20 0.44
▸ MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5616126 0.82 NPC1 (0.57) POLBEPHX2SMN1; SMN2LMNAPKM
SCHEMBL30768879 0.76 POLB (0.80) POLBEPHX2SMN1; SMN2CYP1A2CYP3A4
SCHEMBL8358822 0.76 MMP13 (0.69) SMN1; SMN2CYP3A4LMNAHTTALDH1A1
SCHEMBL4719932 0.76 MAPK14 (0.56) CYP3A4ALDH1A1CYP2D6CYP2C9MMP13
SCHEMBL5615596 0.74 ALDH1A1 (0.50) POLBCYP3A4PKMALDH1A1KMT2A
SCHEMBL5615640 0.73 MMP13 (0.60) SMN1; SMN2CYP3A4LMNAALDH1A1KMT2A
SCHEMBL4720766 0.73 MMP13 (0.73) SMN1; SMN2CYP3A4LMNARAB9ACYP2D6
SCHEMBL8348717 0.73 ROCK1 (0.65) SMN1; SMN2CYP3A4LMNARAB9AKMT2A
SCHEMBL4718560 0.73 MMP13 (0.57) CYP3A4LMNAALDH1A1CYP2D6CYP2C9
SCHEMBL4720432 0.73 MMP13 (0.63) SMN1; SMN2CYP3A4LMNAHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004041788-A1 NOVEL PYRIMIDINE-4,6-DICARBOXAMIDES FOR THE SELECTIVE INHIBITION OF COLLAGENASES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-05-21 — — WO disclosed
Send feedback